Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort Turbuhaler strategy comparison in COPD
ChiCTR-TRC-08000215Phase 3Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of budesonide, tiotropium, formoterol and salbutamol in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Frequency of acute exacerbation of chronic obstructive pulmonary disease and Mortality rate. Started Dec 2008; status: completed.
02
Drugs
budesonidetiotropiumformoterolsalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-08000215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000215.